Two Ru(II) polypyridyl complexes, Ru(DIP)2(bdt) (1) and [Ru(dqpCO2Me)(ptpy)](2+) (2) (DIP = 4,7-diphenyl-1,10-phenanthroline, bdt = 1,2-benzenedithiolate, dqpCO2Me = 4-methylcarboxy-2,6-di(quinolin-8-yl)pyridine), ptpy = 4'-phenyl-2,2':6',2-terpyridine) have been investigated as photosensitizers (PSs) for photodynamic therapy (PDT). In our experimental settings, the phototoxicity and phototoxic index (PI) of 2 (IC50(light): 25.3 M, 420 nm, 6.95 J/cm(2); PI >4) and particularly of 1 (IC50(light): 0.62 M, 420 nm, 6.95 J/cm(2); PI: 80) are considerably superior compared to the two clinically approved PSs porfimer sodium and 5-aminolevulinic acid. Cellular uptake and distribution of these complexes was investigated by confocal microscopy (1) and by inductively coupled plasma mass spectrometry (1 and 2). Their phototoxicity was also determined against the Gram-(+) Staphylococcus aureus and Gram-(-) Escherichia coli for potential antimicrobial PDT (aPDT) applications. Both complexes showed significant aPDT activity (420 nm, 8 J/cm(2)) against Gram-(+) (S. aureus; >6 log10 CFU reduction) and, for 2, also against Gram-(-) E. coli (>4 log10 CFU reduction).
ABSTRACT.
Two Ru(II) polypyridyl complexes, Ru(DIP)2(bdt) (1) and [Ru(dqpCO2Me)(ptpy)] 2+ (2) (DIP = 4,7-diphenyl-1,10-phenanthroline; bdt = 1,2-benzenedithiolate; dqpCO2Me = 4-methylcarboxy-2,6-di(quinolin-8-yl)pyridine); ptpy = 4'-phenyl-2,2':6',2''-terpyridine) have been investigated as photosensitizers (PSs) for photodynamic therapy (PDT). In our experimental settings, the phototoxicity and photo-index (PI) of 2 (IC50(light): 25.3 μM, 420 nm, 6.95 J/cm 2 ; PI: >4) and particularly of 1 (IC50(light): 0.62 μM, 420 nm, 6.95 J/cm 2 ; PI: 80) are considerably superior compared to the two clinically approved PSs porfimer sodium and 5-aminolevulinic. Cellular uptake and distribution of these complexes was investigated by confocal microscopy (1) and by inductively coupled plasma-mass spectrometry (1 and 2). Their phototoxicity was also determined against the Gram-(+) S. aureus and Gram-(−) E. coli for potential antimicrobial PDT (aPDT) applications. Both complexes showed significant aPDT activity (420 nm, 8 J/cm 2 ) against Gram-(+) (S. aureus; >6 log10 CFU reduction) and, for 2, also against Gram-(−) E. coli (>4 log10 CFU reduction).
Introduction.
Cancer has arguably been one of the most studied disease in the last 100 years. Despite enormous research efforts, cancer has caused over eight million casualties or 13% of all deaths worldwide in 2012. 1 The cornerstones of cancer therapy are radiotherapy, surgery and chemotherapy. In the search for better approaches, photodynamic therapy (PDT) has proven to be a promising new, effective and non-invasive chemotherapeutic treatment modality. The general concept of PDT is based on a photosensitizer (PS), an ideally non-toxic molecule with a higher affinity for cancer cells over healthy cells, that can be excited by irradiation with light and reach a triplet excited state through intersystem crossing. In this state, the PS can react with a substrate or solvent molecule (Type I reaction), through hydrogen atom or electron transfer, generating radicals. The PS can also transfer energy to molecular oxygen (Type II reaction), forming most prominently singlet oxygen ( 1 O2). 2, 3 The products of these two types of reactions are highly reactive and have been shown to cause severe cellular stress and to lead to apoptosis and/or necrosis. [4] [5] [6] The advantages of PDT over other cancer therapies are the high spatiotemporal control and the low systemic toxicity of the treatment. 7 Recently, PDT has also been investigated as a new remedy against bacterial infections. 8 The application of antimicrobial PDT (aPDT) is intriguing because, unlike conventional antibiotics, aPDT does not have one specific target but instead affects multiple sites. This drastically decreases the incidence of resistance. In fact, resistance against aPDT has not been observed yet. 9, 10 With the imminent threat of widespread antibiotic resistance, aPDT could be a much needed new approach to fight the rapidly emerging, multidrug resistant superbugs. Since the approval of the first PDT drug (porfimer sodium) in 1993, multiple (13 as of 2003) PDT PSs have reached the market. 2 All of them are macrocyclic organic molecules, mostly porphyrin derivatives but also phtalocyanine-and chlorin-based molecules. 2 These PSs share several drawbacks such as a cumbersome synthesis and purification, poor water solubility and slow clearance leading to prolonged photosensitivity in patients. 11, 12 There is therefore a need for novel PS with better photophysical and biological properties. The biological, chemical and photolytic stability are key properties of a PS for potential PDT applications. Additionally, the PS should also display a high phototoxic index (PI = ratio between toxicity in the dark and upon light irradiation), a high 1 O2 production quantum yield as well as being active at red-NIR wavelengths to allow for a deeper tissue penetration.
Ruthenium complexes have been under investigation for their anticancer activity for decades. [13] [14] [15] [16] [17] [18] They have gained widespread attention since two complexes, namely NAMI-A and KP1019 (and the respective sodium salt KP1339), passed early clinical trials. [19] [20] [21] The use of ruthenium in PDT however, has been quite limited so far. There have been multiple reports on porphyrin PSs decorated with ruthenium-based substituents. The resulting hybrid complexes exhibited significantly higher PIs than the individual moieties. [22] [23] [24] [25] [26] [27] Charlesworth, 28 Carneiro et al. 29 also investigated organic PSs, phtalocyanines, conjugated to ruthenium moieties. Although the increased PIs are promising, this approach is not ideal as it requires an even longer synthetic pathway than the macrocyclic organic PSs alone. Following a similar approach, Zhou and co-workers coordinated hypocrellin B, an easily prepared phototoxic compound, to ruthenium. The resulting complex showed promising photosensitizing and photodamage properties in the red-NIR region superior to the hypocrellin B alone. 30 Another branch in the research of light-activated ruthenium complexes has investigated the ability of such compounds to release ligands and/or undergo ligand exchanges upon light irradiation. For instance Zayat, 31 Salierno and co-workers, 32 have reported complexes that release biologically active molecules upon light irradiation. On the other hand, Sun, 33 Goldbach, 34 Wachter, 35 Sgambellone et al. 36 have described a series of ruthenium complexes which undergo ligand exchange and subsequent DNA binding or even cleavage upon irradiation at red-NIR wavelengths. The use of ruthenium complexes for 1 O2 production has gained attention only in recent years. Notably, Lincoln et al. have reported ruthenium polypyridyl complexes that efficiently produce 1 O2 upon irradiation with white light and exhibit high phototoxic indices in a metastatic melanoma model. 37 These promising, but very limited reports indicate the enormous potential of ruthenium-based PS. Still, the hitherto reported ruthenium PSs are not ideal. The conjugation of ruthenium to porphyrins does not facilitate their already cumbersome synthesis.
Moreover, nuclear DNA might not be optimal target in PDT since DNA damage causes mutagenesis, which can result in resistance to further treatments. 38, 39 Hence, there certainly is still much uncharted chemical space for ruthenium PSs in PDT.
By comparison, in the realm of antibacterial research, ruthenium complexes have only sparingly been studied. There have been some reports on mono-and polynuclear Ru(II) compounds that effectively reduce the viability of different bacterial strains. [40] [41] [42] [43] However, the field of aPDT is still in its infancy and, to our knowledge, no ruthenium PSs have been investigated for this purpose. This motivates further investigations into ruthenium complexes for antimicrobial applications. Recently, we have been applying Ru(II) polypyridyl complexes as PSs in PDT using low light doses at 350/420 nm. The studied complexes showed promising properties with regard to their 1 O2 yields, cellular uptake and phototoxic index. 44 Building on these promising preliminary results, we have embarked on a program to investigate in-depth the use of such complexes as PSs in PDT. Our aim is to develop biologically stable Ru(II)-based PSs with a straight-forward synthesis and purification, high 1 O2 production quantum yield, high PI and possibly alternative target sites.
In the search for novel ruthenium PSs in PDT, we turned our attention to the field of dyesensitized solar cell (DSSC). The role of ruthenium complexes in DSSCs is to absorb sunlight and inject electrons into the conduction band of an electrode. 45, 46 It has been shown that Ru(II) polypyridyl complexes perform very efficiently in DSSCs. [47] [48] [49] [50] [51] [52] [53] The complexes used for DSSCs exhibit interesting photophysical properties, such as light absorption across the visible spectrum and long excited-state lifetimes. [54] [55] [56] [57] These properties make this class of complexes highly interesting as potential PS in PDT. Hence, with the vast number Ru(II) polypyridyl complexes that have been investigated in the field of DSSC, we decided to probe this class of complexes as PSs in PDT. It would not be the first time that metal complexes designed for a specific purpose find a novel application in a completely unrelated field. For instance, compounds originally envisioned for catalysis are being found to be promising drug candidates, e.g. Hoveyda-Grubbs catalysts demonstrated antiproliferative activity against cancer cells similar to cisplatin. 58, 59 We designed our novel, but representative complexes inspired by the work of Islam 54, 55 and Abrahamson et al. 56 For complex 1, we decided to use 4,7-1,10-diphenylphenanthroline (DIP) as the polypyridyl ligand since [Ru(DIP)3] 2+ is a known PS with a high 1 O2 yield (0.97 in MeOD). 60 Islam et al. reported that the absorbance of ruthenium complexes of the type (Ru(X)2(L), where X is a simple polypyridyl ligand, can be tuned by careful choice of L (two examples, Ru(dcbpy)(NCS)2 and Ru(dcbpy)(bdt) are shown in Fig. 1 ; dcbpy: 4,4′-dicarboxy-2,2′bipyridine, bdt: 1,2-benzenedithiol). For bidentate dithiol ligands in particular, extensive redshift of the complexes absorbance has reported. Based on these findings, we chose 1,2benzenedithiol (bdt) as the third ligand due to its structural simplicity. On the other hand, for complex 2, we took into account the large body of research that indicated that tridentate polypyridyl ligands generally lead to broad absorption across the visible spectrum and perform inherently well in DSSC. 57, [61] [62] [63] [64] Also in this case, relatively simple ligands were used, with only one carboxylic acid functionality present. Herein we report the synthesis and characterization of two novel Ru(II) polypyridyl PS (1 and 2, Fig. 1 ), and their phototoxic activity against human cell lines and bacterial strains. 65 Due to the rapid oxidation of the sulfido ligand upon contact with air a complex mixture of products was formed preventing the isolation of 1b. A similar observation was also reported by Begum et al. 66 for a related ruthenium complex.
Consequently, the mixture of differently oxidized species obtained from 1b was dissolved in acetonitrile and oxidized to the disulfinato complex 1 by addition of H2O2 and stirring at room temperature. After purification by column chromatography on silica, 1 could be obtained in 26% yield. The ligands, ptpy (ptpy = 4'-phenyl-2,2':6',2''-terpyridine) and dqpCO2Me (dqpCO2Me = 4-methylcarboxy-2,6-di(quinolin-8-yl)pyridine), were prepared according to literature procedures. 67, 68 Starting from RuCl3, 2b was obtained and used without further purification for the next step. After column chromatography on silica and subsequent counterion exchange, Figure 2 , reveals that while the ptpy ligand is almost planar, the dqpCO2Me ligand is strongly distorted out of the xy-plane. The Ru-N bond lengths and angles (see Table S1 in SI) are in good agreement with those for similar complexes reported in the literature. 69, 70 From the emission spectrum of 1, a luminescence quantum yield of 0.5% in acetonitrile could be calculated according to a standard procedure. 71 Furthermore, the luminescence lifetime was determined in both air-equilibrated (λexc = 440 nm; 189 ± 4 ns) and degassed (λexc = 440 nm; 1130 ± 28 ns) acetonitrile solutions. The results are comparable to those reported for similar Ru(II) polypyridyl complexes, indicating a phosphorescence-type emission. 72 Luminescence lifetimes in the μs-range implicate a long-lived triplet excited state, which is thought to be important for efficient photosensitization. 37 Altogether, complex 1 showed luminescence lifetimes favorable for photosensitization. The luminescence emission spectrum of 2 shows only weak intensity ( Fig S1) , which is reflected by a low emission quantum yield of <0.1%. The luminescence lifetime was measured in toluene since it was below the detection limit when measured in acetonitrile. The lifetime was found to be 12 ± 2 ns under aerated conditions and 30 ± 1 ns in degassed toluene (λexc = 440 nm). These values are in agreement with those reported by Abrahamsson et al. 56 for similar complexes, indicating a fluorescence-type emission.
Stability in Human Plasma. In order to obtain a preliminary insight into the stability of 1 and 2 under physiological conditions, they were incubated in human blood plasma at 37 °C, following our recently developed protocol. 73, 74 No significant changes were observed either in the UV traces or in the ratio between diazepam (internal standard) and 1 and 2, respectively, even after 48 h ( Fig. 3 ). These results suggest that 1 and 2 are stable under physiological conditions for a therapeutically relevant time. Singlet Oxygen Production. To assess the phototoxic potential of 1 and 2, their 1 O2 production quantum yields (ΦΔ) were determined in acetonitrile and phosphate buffered saline (PBS) by means of both an indirect and direct method as recently published by our group. 75 For both methods the complexes were irradiated with 420 nm light. In the first method, 1 O2 production is observed indirectly through the quenching of the absorbance at 420 nm (acetonitrile) or 440 nm (PBS) of N,N-dimethyl-4-nitrosoaniline (RNO) by a trans-annular peroxide adduct formed by the reaction of 1 O2 with histidine in PBS. In acetonitrile, imidazole is used instead of histidine due to the low solubility of the latter in this solvent. By comparison of the quenching rates of our compounds with a reference compound (phenalenone at 420 nm) with a known 1 O2 production rate 76 at a given wavelength, the 1 O2 quantum yield of 1 and 2 could be determined in acetonitrile and PBS at an irradiation wavelength of 420 nm. It is well acknowledged that the measurement of absorbance changes are not highly sensitive. 77 To confirm the results obtained by the indirect assay, another method was employed. 1 O2 displays a characteristic near-IR luminescence that can be observed at 1270 nm with an IR-sensitive detector. This method could only be applied for 1 since 2 did not show a sufficiently high signalto-noise ratio to obtain meaningful results. By comparison of the luminescence intensity measured for 1 with the one of phenalenone, a second set of 1 O2 quantum yields could be obtained for this complex. The measured 1 O2 quantum yields can be seen in Table 1 . All values are expressed as the mean of three independent experiments with a standard deviation of less than 5%. Complex 1 showed an excellent 1 O2 production (ΦΔ(1; ACN)indirect = 0.81; ΦΔ(1;
ACN)direct = 0.92) in acetonitrile. In PBS, both measurement techniques, direct and indirect, were at the detection limit. It is well acknowledged that singlet oxygen in aqueous solution is shortlived (≈3.5 µs) in comparison to acetonitrile (70-80 µs), which has a diminishing influence on the signal intensity. 78 The low signal-to-noise ratio did not allow an estimation with the direct method whereas the indirect method led to a low quantum yield ΦΔ(1; PBS)indirect = 0.04).
Complex 2 showed moderate 1 O2 quantum yields at 420 nm in acetonitrile (ΦΔ(2; ACN)indirect = 0.15) but the direct measurement did not allow an evaluation of the quantum yield due to low signal-to-noise ratio. The different 1 O2 quantum yields for 1 and 2 are probably related to the difference in their luminescence lifetimes. A long luminescence lifetime indicates a long-lived triplet-excited state, which in turn is favorable for photosensitization purposes. 37 For both compounds, the highest 1 O2 quantum yields were measured in the more lipophilic solvent acetonitrile. Since cells do not only have polar but also lipophilic environments, compounds 1 and 2 could prove to be promising PSs. 75 Table 1 . Singlet oxygen quantum yields of 1 and 2, values expressed as mean of three independent experiments (with standard deviation <5%). purposes, the cytotoxicity of the compounds was also determined towards the human fibroblast (MRC-5) non-tumorigenic cell line with cisplatin as a reference. After 4 h incubation time, the medium was replaced with fresh medium (without complex) and the cells were irradiated at 420 nm for 15 min. The corresponding light dose (6.95 J/cm 2 ) is very similar to that used for the clinically approved PS porfimer sodium in comparable experiments (5 J/cm 2 ). 79 The IC50 values for all measurements are shown in Table 2 . It must be noted that for the IC50 values determined without irradiation, two different values were obtained (for HeLa cells) for incubation times of Table 2 ). 79 Since cisplatin has a lightindependent mode of action, the PI is not applicable for this compound. 83 Complex 2 displayed a very promising lack of activity towards non-tumorigenic cells (MRC-5) as well as towards cancerous cells (HeLa) in the dark in the range of concentrations measured in this study (up to 100 μM), while still demonstrating a moderate toxicity (IC50 = 25.3 ± 4.7 μM) upon irradiation and a PI of at least 4. The high phototoxicity observed for 1 upon irradiation at 420 nm is in agreement with the higher 1 O2 quantum yields and stronger absorption observed at this wavelength. Additionally, it is also a type of cancer that is accessible by fiber-optics, which is an essential requirement for PDT applications. 86 Cells were stained with DAPI ( Fig. 4a ) and with the Mitotracker green FM (Fig. 4b ). Complex 1 was visualized with an excitation at 400 nm ( Fig.   4c ), which does not interfere with the other dyes. As can be seen in Fig. 4c , the luminescence of 1 is highly visible. Fig. 4d shows the overlay of Fig 4a-4c . It can be observed that the area of the emission of 1 superimposes extremely well with the emission of the Mitotracker green FM, which localizes in mitochondria. Accumulation of the PS in the mitochondria is promising as they are important cell organelles and their damage can trigger different paths of cell death. 73, 87 We note that very poor photoluminescence of 2 precluded confocal microscopy studies. high phototoxicity, it has to be acknowledged that their cellular uptake into HeLa cells is quite moderate compared to other Ru(II) complexes. 44, 88, 89 To obtain more detailed information about the localization of 1and 2their subcellular accumulation was investigated. Briefly, HeLa cells were incubated with 1 and 2 for 4 h and subsequently the nuclei and mitochondria of the cells were isolated while the remaining cell material was kept as a residual fraction. The two complexes displayed a quite different cellular distribution profile (Fig. 5 ). For 1, the results confirmed the data obtained by the microscopy studies with 67 % of the total Ru taken up by mitochondria (9.1 ± 1.3 ng/mg protein). We have previously observed a similarly high mitochondrial uptake with another class of Ru(II) polypyridyl complexes. 73 In contrast to the microscopy results, a significant amount of Ru could also be observed in the nuclear fraction (28%, 3. and 24 h incubation at 37 °C).
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Conclusions
In a first step to probe the large library of ruthenium compounds used in DSSC in the field of PDT, two novel ruthenium(II) polypyridyl complexes (1 and 2) have been prepared and characterized, including by X-ray crystallography for 2. Their stability in biological media, photophysical properties and 1 O2 production quantum yields have been determined. Both complexes were shown to produce 1 O2. Furthermore, their phototoxicity was evaluated against the human cervical cancer cell line HeLa. Complex 2 displayed phototoxicity in the low micromolar range against HeLa cells and, most importantly, no significant toxicity in dark experiments. Complex 1 showed phototoxicity in the nanomolar range with a PI of 80 against HeLa cells. This result is even more impressive when compared to the clinically approved PS ALA and porfimer sodium which display both lower phototoxicity and PIs in similar experimental settings. 79 With the help of confocal microscopy experiments, 1 was shown to accumulate in the cytoplasm, particularly in mitochondria. These results were confirmed by ICP-MS experiments, which showed an accumulation of around 67% of the total Ru taken up by the cell into the mitochondria. In comparison, the cellular uptake of 2 was shown to be quite more diffuse. In fact, 2 could be detected in all cellular compartments, with a slight preference for the cellular nucleus. Both complexes showed an overal cellular uptake 10-100 times lower than for other ruthenium complexes. 44, 88, 89 Remarkably, 2 and particularly 1 still exhibited moderate to high toxicity upon light irradiation. Improving the cellular uptake of these compounds (e.g. by coupling them to a targeting molecule) could further increase both their toxicity and selectivity against cancer cells.
In the light of the novel up-and-coming field of aPDT, the phototoxicity of 1 and 2 was also Materials. All chemicals were of reagent grade quality or better, obtained from commercial suppliers and used without further purification. The Ligands dqpCO2Me and ptpy were prepared according to literature procedures. 67, 68 The purity of all final compounds was shown to be 95% or higher by elemental microanalysis. Solvents were used as received or dried over molecular sieves. All preparations were carried out using standard Schlenk techniques.
Instrumentation and Methods. 1 Stability in Human Plasma. The stability of the compounds in human plasma at 37 °C was evaluated following a slightly modified procedure to that recently reported by our group. 73, 74 The human plasma was provided by the Blutspendezentrum, Zurich, Switzerland. Diazepam was X-ray Crystallography. Single-crystal X-ray diffraction data were collected at 183(2) K on an Agilent Technologies SuperNova area-detector diffractometer using a single wavelength Enhance X-ray source with Cu K radiation (= 1.5418 Å) 95 from a micro-focus X-ray source and an Oxford Instruments Cryojet XL cooler. The selected suitable single crystal was mounted using polybutene oil on a flexible loop fixed on a goniometer head and immediately transferred to the diffractometer. Pre-experiment, data collection, data reduction and analytical absorption correction 96 were performed with the program suite CrysAlisPro. 97 Using Olex2, 98 The lysates were lyophilized on an Alpha 2-4 LD plus (CHRIST).
Cellular Fractions. HeLa cells were seeded two days before treatment at a concentration of 1x10 6 cells/ml in 175 cm 2 cell culture flask till 80% of confluence and incubated with the target complexes at 20 μM for 4 hours (DMSO concentration < 0.1%). The medium was removed, the cells washed with PBS and trypsinized. After re-suspension in PBS, the pellet was collected per centrifugation (5910R, Eppendorf) at 500 g for 5 min at 4 °C. Mitochondria were isolated using a mitochondria isolation kit (Cat. Nr.: MITISO2, Sigma Aldrich) following the producer instructions. Briefly, the collected pellets were redissolved in 1.5 ml of lysis buffer (delivered with the kit) and allowed to react for 15 min on ice. The samples were homogenized with a prechilled dounce homogenizer (7 ml, tight pestle A, 30 strokes) and centrifuged at 600 g for 10 min at 4 °C. The supernatant was transferred in a fresh tube and centrifuged at 11000 g for 10 min at of HeLa cells were obtained following an established procedure with minor modifications. 102 Immediately thereafter, the bacteria were irradiated with a total light dose of 8 J/cm 2 (time period: 10 min). Control samples were either incubated with PS only or irradiated only without any PS incubation. After irradiation, the surviving bacteria were determined by plating out and enumeration of the colony forming units (CFU per ml). Therefore, serially diluted aliquots of treated and untreated cells were plated on Müller-Hinton agar and the number of CFU per ml was counted after 24 h at 37 °C. The method used to determine the growth of bacteria was originally described by Miles, Mirsa & Irwin. 92 A Müller-Hinton agar plate was divided into six quadrants and three drops of 20 µl each per quadrants were applied of the serially diluted suspensions. After each three drops, the pipette tips were changed. After the droplets were dried, the agar plates were inverted and incubated at 37 °C for 24 h. The day after the surviving colonies were counted, and the three values of the respective dilution steps were summed up and an average value was calculated. A reduction of at least three orders of magnitude (i.e., 3 log10 units) of viable mean numbers of bacteria was stated as biologically relevant with regard to the guidelines of hand hygiene. 104 ASSOCIATED CONTENT 
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